A timeline illustrating highlights from the history of the medical use of cannabis with an emphasis on the treatment of seizures and epilepsy. The history of human use of the Cannabis plant goes back to the dawn of mankind. The plant, which originated in Central Asia or in the foothills. Cannabis is a plant-based, or botanical, product with origins tracing back to the . exert a therapeutic effect for epilepsy, insomnia, and social anxiety disorder.
in History Epilepsy Cannabis of
Access to marijuana through home cultivation, dispensaries, or some other system that is likely to be implemented;. Allows either smoking or vaporization of some kind of marijuana products, plant material, or extract. Schedules of controlled substances. Department of Justice; Management of substance abuse: Behavioral health trends in the United States: Office of National Drug Control Policy.
Answers to frequently asked questions about marijuana. Medicinal use of marijuana—polling results. N Engl J Med. Kondrad E, Reid A. J Am Board Fam Med. Moeller KE, Woods B. Am J Pharm Educ. National Conference of State Legislatures. State medical marijuana laws. Food and Drug Administration. FDA work on medical products containing marijuana. Food and Drug Administration; Mar, A Complete Guide to Cannabis.
Park Street Press; Early medical use of cannabis. The Marihuana Tax Act of The advisability and feasibility of developing USP standards for medical cannabis.
Pharmacopeial Convention; [Accessed August 5, ]. Encyclopedia of Drug Policy. State marijuana laws in map. Comparing cannabis with tobacco—again. National Institute on Drug Abuse. Should marijuana be a medical option? MacDonald K, Pappas K. A multi-facet therapeutic target. Care and feeding of the endocannabinoid system: International Union of Basic and Clinical Pharmacology. Cannabinoid receptors and their ligands: Current status and prospects for cannabidiol preparations as new therapeutic agents.
Zhornitsky S, Potvin S. Cannabidiol in humans—the quest for therapeutic targets. Pharmaceuticals Basel ; 5: Is legalization impacting the way people use cannabis? Int J Drug Policy. Pharmacokinetics and metabolism of the plant cannabinoids, delta9-tetrahydrocannabinol, cannabidiol, and cannabinol. Controlled cannabis vaporizer administration: Plasma delta-9 tetrahydrocannabinol concentrations and clinical effects after oral and intravenous administration and smoking.
Pharmacokinetics and pharmacodynamics of cannabinoids. Exogenous cannabinoids as substrates, inhibitors, and inducers of human drug metabolizing enzymes: Sativex oral mucosal spray. Marinol dronabinol capsules USP prescribing information. Adverse health effects of marijuana use. Association between cannabis and psychosis: Keep off the grass? Cannabis, cognition, and addiction.
Marijuana and lung diseases. Curr Opin Pulm Med. Cannabis use and risk of psychiatric disorders: Early cannabis use and estimated risk of later onset of depression spells: Cannabis, ischemic stroke, and transient ischemic attack: Adverse cardiovascular, cerebrovascular, and peripheral vascular effects of marijuana: Acute and long-term effects of cannabis use: Examining the roles of cannabinoids in pain and other therapeutic indications: Adverse effects of medical cannabinoids: Lynch ME, Campbell F.
Cannabinoids for treatment of chronic noncancer pain: Br J Clin Pharmacol. Cannabinoids for nausea and vomiting in adults with cancer receiving chemotherapy. Cochrane Database Syst Rev. Gloss D, Vickrey B. American Academy of Neurology. Efficacy and safety of the therapeutic use of medical marijuana cannabis in selected neurologic disorders.
Efficacy and safety of medical cannabinoids in older subjects: Cannabidiol, in an oral-mucosal spray formulation combined with deltatetrahydrocannabinol, is a product available by prescription only until for relief of severe spasticity due to multiple sclerosis where other anti- spasmodics have not been effective.
Until , products containing cannabidiol marketed for medical purposes were classed as medicines by the UK regulatory body , the Medicines and Healthcare products Regulatory Agency MHRA and could not be marketed without regulatory approval for the medical claims. A literature review indicated that cannabidiol was under basic research to identify its possible neurological effects,  although as of [update] , there was limited high-quality evidence for such effects in people.
From Wikipedia, the free encyclopedia. Not to be confused with Cannabinol or Cannabinodiol. S4 Prescription only UK: Schedule I except Epidiolex, Schedule V. Drug culture Illegal drug trade Psychedelia. Retrieved 28 June Journal of Clinical Pharmacology. Pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders". Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences Review. State of the art and new challenges for therapeutic applications".
Implications for Treating Anxiety-Related Disorders". Journal of Natural Products. US Food and Drug Administration. Retrieved 25 June Retrieved 1 November Hard Evidence at Last? Annals of Clinical Psychiatry. A Systematic Review of the Evidence". British Journal of Clinical Pharmacology. A Comprehensive Update of Evidence and Recommendations".
American Journal of Public Health. Cannabis and Cannabinoid Research. Drug Metabolism and Disposition. Journal of Biological Chemistry. British Journal of Pharmacology. Naunyn-Schmiedeberg's Archives of Pharmacology. Therapeutics and Clinical Risk Management. On the nature of the Beam test". Structure elucidation of four pyrolytic products , doi: An improved synthesis of cannabidiol".
Journal of Experimental Botany. Food and Drug Administration. Retrieved January 2, Trends in Pharmacological Sciences. Department of Agriculture, State of Colorado. Retrieved 14 September Cannabidiol is illegal and always has been". Retrieved December 10, Retrieved 14 May National Conference of State Legislatures. Retrieved 13 January Retrieved 6 November Retrieved January 3, The Farm Bill.
Retrieved January 29, I had a child who had failed 15 medications and drug treatments and there was nothing else to do, and they were having many seizures a day that were terribly disabling, I think it would be a very reasonable thing to do to try a high-CBD cannabis product. He also expressed concern that the number of parents using the Charlotte's Web extract will make it harder to find children for the clinical trials, and that:.
There are many more unknowns than knowns That should be the real focus of what we need right now. The Epilepsy Foundation and Devinsky issued a joint statement calling for increased research and immediate access to medical marijuana, specifically naming Charlotte Figi's case. We need to make a balanced decision about compassionate use.
And as a doctor, I would gladly prescribe marijuana products for many of my patients who failed existing therapies if it were legal in my state.
Until we have the scientific data, we should make medical marijuana available to physicians who care for people with treatment-resistant epilepsy and their patients. Due to reports that some people with Dravet syndrome seem to benefit from treatment with Charlotte's Web, an observational clinical trial was launched in September at the University of Colorado.
In January , it was reported that trials with Epidiolex, a high-CBD pharmaceutical, had been successful enough that it might be "available as soon as the second half of in the United States, pending Food and Drug Administration approval. From Wikipedia, the free encyclopedia. Drug culture Illegal drug trade Psychedelia. Colorado family makes good in medical pot business". Retrieved February 21, The Cochrane Database of Systematic Reviews 3: To many in the medical community, these parents are relying, at best, on shaky science.
A Cochrane review of studies examining CBD as a treatment for epilepsy concluded that, due to the dearth of large, high-quality studies, 'the safety of long-term cannabidiol treatment cannot be reliably assessed. New England Journal of Medicine. See full CNN video.
Retrieved December 7, To amend the Controlled Substances Act to exclude therapeutic hemp and cannabidiol from the definition of marihuana, and for other purposes. Charlotte's Web Medical Hemp Act of ". Industrial Hemp Farming Act of ". Charlotte's Web Medical Access Act of ". Therapeutic Hemp Medical Access Act of ". Retrieved November 4, Retrieved April 13, Retrieved April 21, Retrieved August 25, Retrieved September 15, Retrieved January 26, Recreational and medical applications rights Industrial applications.
Autoflowering cannabis Cannabis indica ruderalis sativa Difference between C. Medical cannabis History Timeline Religious and spiritual use Chalice.
Cannabis in pregnancy Dependence Effects of cannabis Long-term Endocannabinoid system Impaired driving. Adult lifetime use by country Annual use by country. Return to class B Uruguay:
There was a problem providing the content you requested
Epilepsy Behav. May;70(Pt B) doi: /softwareengineeringbooks.info Epub Jan Historical perspective on the medical use of cannabis for. Epilepsy Action Australia publishes regular email updates MedCann on the progress of all aspects of medicinal cannabis use in epilepsy. Register to receive . The use of cannabis to treat epilepsy and other neurological conditions has been studied for a number of years. It has been hotly debated too. On June 25,